Transcriptomics profiling shows that deleting SHMT2 promotes the expression of the DNL pathway while reducing inflammation and fibrosis pathways in the diet-induced NAFLD model. The gene discussed is SHMT2; the disease is metabolic dysfunction-associated steatotic liver disease.